Torsemide and Lucentis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Torsemide (torsemide) and Lucentis (ranibizumab). Common drug interactions include cerebral infarction among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Torsemide and Lucentis. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Torsemide?

Torsemide has active ingredients of torsemide. It is often used in high blood pressure. eHealthMe is studying from 33,072 Torsemide users. Check the latest studies of Torsemide.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

On Jul, 26, 2026

28 people who take Torsemide and Lucentis together, and have interactions are studied.

Torsemide and Lucentis drug interactions.

What are the common drug interactions of Torsemide and Lucentis, by gender? *:

female:

Cerebral infarction (less blood supply to brain resulting tissue damage)
Endophthalmitis (inflammation of the internal coats of the eye)
Joint swelling
Retinal artery occlusion (blockage of retinal artery)
Retinal degeneration (death of the cells of the retina)
Hallucination (an experience involving the perception of something not present)
Intraocular pressure increased
Dizziness
Death
Palpitations (feelings or sensations that your heart is pounding or racing)

male:

Fatigue (feeling of tiredness)
Nasal disorder (diseases of nose)
Anaemia (lack of blood)
Anaemia postoperative
Bone density decreased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Chronic leukaemia (long lasting blood cell cancer)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Fall

What are the common drug interactions of Torsemide and Lucentis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pneumonia

40-49:

n/a

50-59:

Myalgia (muscle pain)
Neck pain
Neuropathy peripheral (surface nerve damage)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Pain
Pain in extremity
Peripheral swelling
Pneumonia
Presyncope
Pulmonary hypertension (increase in blood pressure in the lung artery)

60+:

Fatigue (feeling of tiredness)
Urinary tract infection
Bone density decreased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Chronic leukaemia (long lasting blood cell cancer)
Depression
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Fall
Femur fracture

What are the existing conditions these people have? *

Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 9 people, 32.14%
Age-Related Macular Degeneration: 5 people, 17.86%
High Blood Cholesterol: 4 people, 14.29%
Urinary Tract Infection: 3 people, 10.71%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 10.71%
Diabetes: 3 people, 10.71%
Rashes (redness): 2 people, 7.14%
Constipation: 2 people, 7.14%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Torsemide and Lucentis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously